FI962264A - Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana - Google Patents

Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana Download PDF

Info

Publication number
FI962264A
FI962264A FI962264A FI962264A FI962264A FI 962264 A FI962264 A FI 962264A FI 962264 A FI962264 A FI 962264A FI 962264 A FI962264 A FI 962264A FI 962264 A FI962264 A FI 962264A
Authority
FI
Finland
Prior art keywords
active ingredient
formation inhibitor
causes information
cytokine formation
polyprenyl derivative
Prior art date
Application number
FI962264A
Other languages
English (en)
Swedish (sv)
Other versions
FI962264A0 (fi
Inventor
Akikuni Yagita
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI962264A0 publication Critical patent/FI962264A0/fi
Publication of FI962264A publication Critical patent/FI962264A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI962264A 1993-12-01 1996-05-30 Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana FI962264A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30075193 1993-12-01
PCT/JP1994/001971 WO1995015159A1 (fr) 1993-12-01 1994-11-22 Inhibiteur de la production de cytokines inflammatoires, contenant un derive polyprenyle comme principe actif

Publications (2)

Publication Number Publication Date
FI962264A0 FI962264A0 (fi) 1996-05-30
FI962264A true FI962264A (fi) 1996-07-05

Family

ID=17888662

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962264A FI962264A (fi) 1993-12-01 1996-05-30 Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana

Country Status (13)

Country Link
US (1) US5708037A (fi)
EP (1) EP0806204A4 (fi)
KR (1) KR960706333A (fi)
CN (1) CN1142765A (fi)
AU (1) AU683112B2 (fi)
CA (1) CA2177966A1 (fi)
CZ (1) CZ282294B6 (fi)
FI (1) FI962264A (fi)
HU (1) HUT74983A (fi)
NO (1) NO962212L (fi)
NZ (1) NZ276178A (fi)
RU (1) RU2141318C1 (fi)
WO (1) WO1995015159A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11180873A (ja) * 1997-12-22 1999-07-06 Kaken Shoyaku Kk ＮＦ−κＢ活性阻害剤
US20040022787A1 (en) 2000-07-03 2004-02-05 Robert Cohen Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID
MXPA02012603A (es) * 2000-07-03 2003-05-14 Squibb Bristol Myers Co Metodos para tratamiento de enfermedades reumaticas utilizando una molecula de ctla4 soluble.
KR100448488B1 (ko) * 2001-09-03 2004-09-13 (주)프로테옴텍 베체트병의 질병 표시인자로서의 아포리포프로테인에이-1을 이용한 진단 시스템
DE60316938T2 (de) * 2002-05-17 2008-07-17 Gen-Probe Inc., San Diego Probenträger mit lösbarer sperreinrichtung
MD480Z (en) * 2011-07-07 2012-09-30 Elvira Andon Method for treating acute ulcerative nonspecific colitis
CN108358788A (zh) * 2017-02-04 2018-08-03 周厚广 有机物对映体纯oa及其在制备ⅱ型糖尿病及血管并发症药物中的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192953A (en) * 1975-11-18 1980-03-11 Sankyo Company Limited Polyprenyl derivatives
US4059641A (en) * 1975-11-18 1977-11-22 Sankyo Company Limited Polyprenyl derivatives
JPS57154123A (en) * 1981-03-17 1982-09-22 Sankyo Co Ltd Remedial promotor for wound

Also Published As

Publication number Publication date
NZ276178A (en) 1997-08-22
CN1142765A (zh) 1997-02-12
EP0806204A1 (en) 1997-11-12
RU2141318C1 (ru) 1999-11-20
NO962212D0 (no) 1996-05-30
WO1995015159A1 (fr) 1995-06-08
FI962264A0 (fi) 1996-05-30
US5708037A (en) 1998-01-13
CZ282294B6 (cs) 1997-06-11
EP0806204A4 (en) 2001-06-27
AU1034695A (en) 1995-06-19
CA2177966A1 (en) 1995-06-08
HUT74983A (en) 1997-03-28
AU683112B2 (en) 1997-10-30
CZ156696A3 (en) 1997-01-15
KR960706333A (ko) 1996-12-09
NO962212L (no) 1996-07-31

Similar Documents

Publication Publication Date Title
FI925615A (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reduktas-inhibitorfoerening
FI921312A0 (fi) Hoegmobila integrerade drivers foer aktiva matrisdisplays.
FI921182A0 (fi) Velangummi som snabbt hydratiseras.
FI921606A0 (fi) Mikroperoxidas innehaollande hemopeptid som aktiv komponent.
NO980467L (no) 4-mercaptopyrrolidin-derivater som farnesyl-transerase-inhibitorer
NO940305D0 (no) Kinazolin-derivater som acetylcholin-esteraseinhibitorer
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
DK0606248T3 (da) Heteroarylaminer som hidtil ukendte acetylcholinesteraseinhibitorer
FI922973A0 (fi) Tokoferolblandning foer anvaendning som antioxidant foer krusmyntolja i tuggummi.
NO923089D0 (no) Tetrahydroindazol, tetrahydrocyklopentapyrazol og heksahydrocykloheptapyrazol forbindelser og deres anvendelse som hmg-coa reduktase-hemmere
MX9204375A (es) Gen activador para la biosintesis de macrolidos.
NO922167D0 (no) Aminodukter som korrosjonshemmere
FI962264A (fi) Tulehduksia aiheuttavan sytokiinin muodostumisen inhibiittori, joka käsittää polyprenyylin johdannaisia aktiivisena ainesosana
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
FI923777A (fi) Inloppslaoda, som har vaetskestraolstoed
FI914991A0 (fi) Plywood som foerhindrar spridning av brand.
FI913578A0 (fi) Doerrstrapets som monteras i doerroeppning.
FI910937A (fi) Engaongsdaempare foer anordning som hindrar medfallande.
FI914989A0 (fi) Kraftverk som anvaender stroemmande vatten.
NO950212D0 (no) Indolinyl-N-hydroksyurinstoff- og -N-hydroksamsyrederivater som lipoksygenase-inhibitorer
FI921234A0 (fi) Saekerhetsanordning som avstaenger oljekaellans produktionsledning.
FI922997A0 (fi) Tuggummi som innehaoller verksamma aemnen.
FI914990A0 (fi) Plywood som ersaetter panelning.
ZA922501B (en) Thid-carboxylic acid derivatives as collagenase inhibitors.
FI914964A0 (fi) Foerfarande foer reparation av raefflan som slitits av sugvalsens aendtaetning i en pappersmaskin.